Nanotechnology meets liver cancer: liposomal immunotherapy strategies for hepatocellular carcinoma
Liposomes are a revolutionary approach in cancer immunotherapy. Innovations like PEGylation, surface ligand modification, and dual-drug encapsulation have significantly enhanced treatment outcomes in preclinical and early clinical contexts. Advancements, especially in patient-specific and stimuli-responsive systems, may transform the future of HCC care.
Authors
- Shruti Srivastava (ORCID: https://orcid.org/0000-0002-7200-7311)
- Ankush Kansal (ORCID: https://orcid.org/0000-0002-3975-354X)
- Ayush Singh (ORCID: https://orcid.org/0000-0002-4737-3424)
- Dev Kashyap
- Amanpreet Kaur (ORCID: https://orcid.org/0000-0002-5499-777X)
- Vipin Saini (ORCID: https://orcid.org/0000-0003-2881-042X)
- Jagpreet kour
- Manish Kumar (ORCID: https://orcid.org/0000-0002-6021-7063)
Institutions
- Chandigarh University (IN)
- Sri Guru Granth Sahib World University (IN)
- Indo Soviet Friendship College of Pharmacy (IN)
- Gurukul School of Design (IN)
- Diagnostický Ústav pro Mládež (CZ)
- Hindu College of Pharmacy (IN)
Publication Details
- Journal
- Expert Review of Anticancer Therapy
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1080/14737140.2025.2575017
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32